| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,086,000 | 2,550,000 | 2,445,000 | 2,283,973 | | Cost of Revenue | 301,000 | 330,000 | 366,000 | 407,458 | | | Gross Profit |
-
| 2,220,000 | 2,079,000 | 1,876,515 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,168,000 | 1,231,000 | 1,058,000 | 1,040,211 | | Non Recurring | 75,000 |
-
|
-
| 6,099,000 | | Others | 1,025,000 | 912,000 | 425,000 | 1,284,139 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 77,000 | 596,000 | (6,546,835) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (483,000) | 77,000 | 596,000 | (6,546,835) | | Interest Expense | 168,000 | 190,000 | 204,000 | 249,898 | | Income Before Tax | (651,000) | (113,000) | 392,000 | (6,796,733) | | Income Tax Expense | (274,000) | 75,000 | 315,000 | (578,706) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (377,000) | (188,000) | 77,000 | (6,218,027) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (269) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (377,000) | (188,000) | 77,000 | (6,218,296) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (26,236) | | | Net Income Applicable To Common Shares | ($544,000) | ($188,000) | $77,000 | ($6,244,532) |
|
0.04% Nasdaq 
0.36%
Income Statement
